SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma
Clinical trial NCT04205630 · COMPLETED
Trial details
- NCT number
- NCT04205630
- Sponsor
- Byondis B.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-28
- Primary completion
- 2023-01-26
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.